Genelux's Unattributed VC Round

Genelux raised a round of funding on June 05, 2012. Investors include AbbVie Biotech Ventures.

Genelux is a clinical stage biopharmaceutical company with a mission to change the way in which cancer is diagnosed and treated. The company has developed an oncolytic virus-based technology platform …

Articles about Genelux's Unattributed VC Round: